Vascular Clips for Preventing Lymphocele and Symptomatic Lymphocele in Patients With Gynecologic Malignancies After Laparoscopic Pelvic Lymphadenectomy

被引:0
|
作者
Zhao, Luyang [1 ]
Xie, Xiufeng [1 ]
Fan, Wensheng [1 ]
Wen, Yang [1 ]
Zhang, Nina [1 ]
Xu, Jia [1 ]
Meng, Yuanguang [1 ]
Gu, Chenglei [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 7, Dept Obstet & Gynaecol, 5 Nanmencang, Beijing 100700, Peoples R China
关键词
Lymphocele; Symptomatic lymphocele; Pelvic lymphadenectomy; Gynecologic malignancy; Complication; NODE DISSECTION; CANCER; COMPLICATIONS; MANAGEMENT; SURGERY;
D O I
10.1016/j.jmig.2024.06.011
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Study objective: To evaluate the effectiveness of using vascular clips to seal targeted lymphatics in gynecological malignancies for the prevention of postoperative pelvic lymphocele and symptomatic lymphocele after laparoscopic pelvic lymphadenectomy. Design: Retrospective analysis. Setting: Single-center academic hospital. Patients: In total, 217 patients with gynecological malignancies were included. Interventions: Patients were classified into two groups: group 1 (vascular clips were used to seal the targeted lymphatics) and group 2 (electrothermal instruments were used to seal the targeted lymphatics). The patients were followed up 4-6 weeks after surgery to evaluate the incidence of lymphoceles by ultrasound or CT. Symptomatic lymphoceles are defined as those that cause infection, deep vein thrombosis with or without swelling of the extremities, edema (swelling) of the extremities or perineum, hydronephrosis, and/or moderate to severe pain. Measurements and main results: One hundred and thirteen patients were enrolled in group 1, and 104 patients were enrolled in group 2. Lymphoceles were observed in 46 (21.2%) patients. Fewer lymphoceles occurred in group 1 than in group 2 (8 [7.1%] vs. 38 [36.5%], p <.001). The percentage of significantly sized lymphoceles was lower in group 1 than that in group 2 (4 [3.5%] vs. 30 [28.8%], p <.001]. Symptomatic lymphoceles occurred in 18 patients (8.3%), and only one (1.0%) occurred in group 1, while 17 (16.3%) occurred in group 2 (p <.001). A multivariate analysis revealed that vascular clips were the only independent factor for preventing lymphocele (OR = 7.65, 95% CI = [3.30-17.13], p <.001) and symptomatic lymphocele (OR = 22.03, 95% CI = [2.84-170.63], p = .003). Conclusion: The results indicate that the use of vascular clips may be useful for the prevention of the development of lymphocele and symptomatic lymphocele secondary to pelvic lymphadenectomy performed via laparoscopy.
引用
收藏
页码:875 / 881
页数:7
相关论文
共 41 条
  • [21] Laparoscopic lymphocele fenestration in gynaecological cancer patients after retroperitoneal lymph node dissection as a first-line treatment option
    Radosa, M. P.
    Diebolder, H.
    Camara, O.
    Mothes, A.
    Anschuetz, J.
    Runnebaum, I. B.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 (05) : 628 - 636
  • [22] Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: a prospective randomized controlled study
    Kim, Yun Hwan
    Shin, Hyun Joo
    Ju, Woong
    Kim, Seung-Cheol
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2017, 28 (03)
  • [23] Prevention of Lymphoceles Using FloSeal and CoSeal After Laparoscopic Lymphadenectomy in Patients With Gynecologic Malignancies
    Koehler, Christhardt
    Kyeyamwa, Sarah
    Marnitz, Simone
    Tsunoda, Audrey
    Vercelino, Filiberto
    Schneider, Achim
    Favero, Giovanni
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2015, 22 (03) : 451 - 455
  • [24] Transperitoneal laparoscopic pelvic lymphadenectomy for gynecologic malignancies (I) - Technique and results
    Lecuru, F
    Taurelle, R
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 1998, 12 (01): : 1 - 6
  • [25] Transperitoneal laparoscopic pelvic lymphadenectomy for gynecologic malignancies (I): Technique and results
    Lécuru F.
    Taurelle R.
    Surgical Endoscopy, 1998, 12 (1) : 1 - 6
  • [26] Percutaneous sclerotherapy with OK-432 for lymphocele after pelvic or para-aortic lymphadenectomy: preliminary results
    Kashiwagi, Eiji
    Ono, Yusuke
    Yano, Hiroki
    Kosai, Shinya
    Nagai, Keisuke
    Tanaka, Kaishu
    Higashihara, Hiroki
    Tomiyama, Noriyuki
    CVIR ENDOVASCULAR, 2022, 5 (01)
  • [27] Efficacy of octreotide to reduce lymphorrhea and prevent lymphocele after pelvic lymph node excision in gynecological malignancies
    Gao, Lingling
    Wang, Siying
    Xu, Jianbo
    Lu, Dan
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2023, 49 (08) : 2151 - 2156
  • [28] Use of TachoSil® to Prevent Symptomatic Lymphocele after an Aggressive Tumor Debulking with Lymphadenectomy for Advanced Stage Ovarian Cancer. A Pilot Study
    Minig, Lucas
    Patrono, Maria Guadalupe
    Cardenas-Rebollo, Jose Miguel
    Marfil, Pedro Martin
    Rodriguez-Tabares, Virginia
    Chuang, Linus
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2016, 81 (06) : 497 - 503
  • [29] Safety and Feasibility Analysis of Laparoscopic Lymphadenectomy in Pelvic Gynecologic Malignancies A Prospective Study
    Benito, Virginia
    Romeu, Silvia
    Esparza, Miriam
    Carballo, Sonia
    Arencibia, Octavio
    Medina, Norberto
    Lubrano, Amina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1704 - 1710
  • [30] Radiotherapy in Prostate Cancer Patients With Pelvic Lymphocele After Surgery: Clinical and Dosimetric Data of 30 Patients
    Jereczek-Fossa, Barbara Alicja
    Colangione, Sarah Pia
    Fodor, Cristiana
    Russo, Stefania
    Cambria, Raffaella
    Zerini, Dario
    Bonora, Maria
    Cecconi, Agnese
    Vischioni, Barbara
    Vavassori, Andrea
    Matei, Deliu Victor
    Bottero, Danilo
    Brescia, Antonio
    Musi, Gennaro
    Mazzoleni, Federica
    Orsi, Franco
    Bonomo, Guido
    De Cobelli, Ottavio
    Orecchia, Roberto
    CLINICAL GENITOURINARY CANCER, 2015, 13 (04) : E223 - E228